NASDAQ: AMRXAmneal Pharmaceuticals Inc Stock Ownership - Who owns Amneal Pharmaceuticals?
Insider buying vs selling
Have Amneal Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jason B. Daly | EVP Chief Legal Officer | 2025-08-12 | 22,000 | $9.05 | $199.10kSell |
| Andrew S. Boyer | Executive Vice President | 2025-08-12 | 33,436 | $9.05 | $302.60kSell |
| Nikita Shah | Executive Vice President | 2025-08-12 | 50,000 | $9.04 | $452.00kSell |
| Gautam Patel | Director | 2025-06-16 | 94,906 | $8.02 | $761.15kSell |
| Gautam Patel | Director | 2025-06-10 | 56,426 | $8.02 | $452.54kSell |
| Nikita Shah | Executive Vice President | 2025-05-16 | 49,140 | $7.58 | $372.48kSell |
| John Kiely | Director | 2025-05-12 | 50,000 | $7.59 | $379.50kSell |
| Gautam Patel | Director | 2025-05-05 | 4,900 | $8.00 | $39.20kSell |
| Gautam Patel | Director | 2025-05-02 | 3,768 | $8.00 | $30.14kSell |
| Gautam Patel | Director | 2025-04-01 | 80,000 | $8.30 | $664.00kSell |
AMRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AMRX insiders and whales buy or sell their stock.
AMRX Shareholders
What type of owners hold Amneal Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Tushar Bhikhubhai Patel | 49.58% | 155,734,627 | $1.46B | Insider |
| Gautam Patel | 15.27% | 47,954,644 | $450.77M | Insider |
| Dipan Patel | 8.57% | 26,905,073 | $252.91M | Insider |
| Dipan 1. Patel | 8.57% | 26,905,073 | $252.91M | Insider |
| Chintu Patel | 8.16% | 25,617,285 | $240.80M | Insider |
| Chirag K. Patel | 7.05% | 22,127,400 | $208.00M | Insider |
| Fosun International Ltd | 5.86% | 18,407,656 | $173.03M | Insider |
| Vanguard Group Inc | 5.59% | 17,551,391 | $164.98M | Institution |
| Ambient Impact Hk Ltd | 5.23% | 16,438,356 | $154.52M | Insider |
| Tpg Group Holdings Sbs Advisors Inc | 5.16% | 16,213,367 | $152.41M | Insider |
AMRX vs Pharmaceutical Stocks
Amneal Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.